Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy

European Journal of Heart Failure

Volumn 14, Issue 7, 2012, Pages 718-729

  Mureddu, Gian Francesco ^a   Agabiti, Nera ^b   Rizzello, Vittoria ^a   Forastiere, Francesco ^b   Latini, Roberto ^c   Cesaroni, Giulia ^b   Masson, Serge ^c   Cacciatore, Giuseppe ^a   Colivicchi, Furio ^d   Uguccioni, Massimo ^e   Perucci, Carlo Alberto ^a   Boccanelli, Alessandro ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e A Alesini Hospital   (Italy)

Author keywords

Asymptomatic left ventricular dysfunction; Elderly; Heart failure; Prevention

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ALGORITHM; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GERIATRIC PATIENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; ITALY; LOGISTIC MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREVALENCE; RISK FACTORS; SEX FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84862883341     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs052     Document Type: Article

References (44)

1. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008;117:2544-2565.
2. Database of the Italian Ministry of Health. Statistics of hospital admissions. Available at: http://www.salute.gov.it/ricoveriOspedalieri/ric- informazioni/interrogad. jsp.
3. Hedberg P, Lönnberg I, Jonason T, Nilsson G, Pehrsson K, Ringqvist I. Left ventricular systolic dysfunction in 75-year-old men and women. A population-based study. Eur Heart J 2001;22:676-683. (Pubitemid 32622428)
4. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, Gouveia Oliveira A, on behalf of the EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531-539. (Pubitemid 36564974)
5. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodehelfer RJ. Burden of systolic and diastolic ventricular dysfunction in the community. J Am Med Assoc 2003;289:194-202.
6. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JCM, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 2004;25:1614-1619. (Pubitemid 39209281)
7. Hunt SA, Abraham WT, Chin MH et al ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2005;46:e1-e82. (Pubitemid 41316530)
8. The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure 2005. Eur J Heart Fail 2005;26:1115-1140.
9. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
10. Mc Donagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJV, Dargie HJ. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-833. (Pubitemid 27404343)
11. Davies MK, Hobbs FR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001;358:439-444. (Pubitemid 32769849)
12. Wang TJ, MD, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977-998.
13. Abhayaratna WP, Marwivk TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006;92:1259-1264. (Pubitemid 44298875)
14. Abhayaratna WP, Smith WT, Becker NG, Marwick TH, Jeffery I M, McGill DA. Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study. Med J Aust 2006;184:151-154.
15. Cesaroni G, Agabiti N, Rosati R, Forastiere F, Perucci CA. An index of socioeconomic position based on 2001 Census, Rome. Epidemiol Prev 2006;30: 352-357.
16. MONICA Manual, Part III: Population Survey Section 1: Population Survey Data Component. December 1997. Available at: http://www.ktl.fi/publications/ monica/manual/part3/iii-1.htm.
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106: 3143-3421.
18. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira 1AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550. (Pubitemid 47614269)
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St. John Sutton M, Stewart. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108. (Pubitemid 43257193)
20. Zile MR, Tanaka R, Lindroth JR, Spinale F, Carabello BA, Mirsky I. Left ventricular volume determined echocardiographically by assuming a constant left ventricular epicardial long-axis/short-axis dimension ratio throughout the cardiac cycle. J Am Coll Cardiol 1992;20:986-993
21. de Simone G, Devereux RB, Ganau A, Hahn R, Saba PS, Mureddu GF, Roman MJ, Howard BV. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. Am J Cardiol 1996;78:801-807. (Pubitemid 126657152)
22. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Aldermann MH, Laragh JH. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451. (Pubitemid 24158016)
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigembaum H, Gutsegell H, Reicheck N, Sahn D, Schnittger I et al Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 1989; 2:358-367.
24. Oh JK, Hatle L, Tajik J, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006;47:500-506. (Pubitemid 43170836)
25. Gosse P, de Simone G, Dubourg O, Gueret P, Schmieder R. Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? J Hypertens 2004;22:1813-1818. (Pubitemid 39141975)
26. Verdecchia P, Angeli F, Reboldi G, Carluccio E, Benemio G, Gattobigio R, Borgioni C, Bentivoglio M, Porcellati C, Ambrosio G. Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am J Hypertens 2003; 16:646-652. (Pubitemid 36900587)
27. Boccanelli A, Mureddu GF, Cacciatore G, Latini R, Masson S, Porcu M, Vanasia M, Maggioni AP, de Simone G Antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure (AREA IN CHF): final results. Eur J Heart Fail 2009;11:68-76.
28. Cowie MR, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC. Incidence and aetiology of heart failure. A population-based study. Eur Heart J 1999;20:421-428. (Pubitemid 29116538)
29. Borlaug BA, Lam CSP, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009; 54:410-418.
30. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996;93:259-265. (Pubitemid 26031483)
31. Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail 2011;13:142-147.
32. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008; 10:933-989.
33. Barsheshet A, Shotan A, Cohen E, Garty M, Goldenberg I, Sandach A, Behar S, Zimlichaman E, Lewis BS, Gottlieb S, for the HFSIS Steering Committee and Investigators. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail 2010;12:833-840.
34. Bursi F, Weston S, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-2216. (Pubitemid 44708051)
35. Mahadevan G, Dwivedi G, Williams L, Steeds RP, Frenneaux M. Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. Eur J Heart Fail 2012;14:106-112.
36. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of future heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350-1355. (Pubitemid 27208618)
37. Raimond I, Pedersen F, Steensgaard-Hansen F, Green A, Busch-Sorensen M, Tuxen C, Appel J, Jacobsen J, Atar D, Hildebrandt P. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart 2003;89:1422-1429. (Pubitemid 37465240)
38. Vinch CS, Aurigemma GP, Simon HU, Hill JC, Tighe DA, Meyer TE. Analysis of left ventricular systolic function using midwall mechanics in patients .60 years of age with hypertensive heart disease and heart failure. Am J Cardiol 2005; 96:1299-1303. (Pubitemid 41505413)
39. de Simone G, Greco R, Mureddu GF, Romano C, Guida R, Celentano A, Contaldo F. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000;101:152-157. (Pubitemid 30044254)
40. Kuznetsova T, Herbots L, Lopez Begoña, Jin Y, Richart T, Thijs L, Gonzalez A, Herregods MC, Fagard RHt, D?́ez J, Staessen JA. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009;2:105-112.
41. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-353. (Pubitemid 43063253)
42. Eggers KM, Lindahl B, Venge P, Lind L. B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years. Am J Cardiol 2009;103:1032-1038.
43. Cheng D, Branscum AJ, Stamey JD. Accounting for response misclassification and covariate measurement error improves power and reduces bias in epidemiologic studies. Ann Epidemiol 2010;20:562-567.
44. Eriksson AK, Ekbom A, Hilding A, Ostenson CG. The influence of non-response in a population-based cohort study on type 2 diabetes evaluated by the Swedish Prescribed Drug Register. Eur J Epidemiol 2011;in press.